IPO Dekho .in

Mangal Compusolution IPO Subscription Status

Mangal Compusolution IPO subscription started on 12 November, 2024 and will close on 14 November, 2024. The retail quota is 50%, QIB is [.]% and NII is 50%. Mangal Compusolution IPO got a lot of interest, raising around ₹16.23 Crores, with subscriptions 34.59 times overall, including [.] times by institutional investors, 22.28 times by non-institutional investors, and 46.91 times by retail investors. Shares are priced between ₹45 each and will be listed on the BSE.
  Check Live IPO  Subscription List  👈
Listed
Last Updated - November 14, 2024 11:57 pm

Mangal Compusolution IPO Subscription - Day 3

QIB - Qualified Institutional Buyers: [.]x
NII - Non-Institutional Investors: 22.28x
SNII - Small Non-Institutional Investors: [.]x
BNII - Big Non-Institutional Investors: [.]x
RII - Retail Individual Investor: 46.91x
Total: 34.59x 👈

Mangal Compusolution IPO Investor Categories

  • Qualified Institutional Buyers: QIB
  • Non-Institutional Investors: NII
  • Small Non-Institutional Investors: SNII- Bid below ₹10L
  • Big Non-Institutional Investors: BNII- Bid above ₹10L
  • Retail Individual Investor: RII
  • Employees Quota: EMP

Mangal Compusolution IPO Dates

IPO Activity Date
Open Date: 12 November, 2024
Close Date: 14 November, 2024
Allotment Date: 18 November, 2024
Refund Date: 19 November, 2024
Shares Credit Date: 19 November, 2024
Listing Date: 20 November, 2024

Mangal Compusolution IPO Subscription Status FAQs

Q.When Mangal Compusolution IPO Subscription will start?

Ans.The IPO subscription starts on 12 November, 2024 for Investors.


Q.What is the Mangal Compusolution IPO Subscription last date?

Ans.Mangal Compusolution IPO subscription last date is 14 November, 2024 for Investors.


Q.What is the Mangal Compusolution IPO Allotment Date?

Ans.Mangal Compusolution IPO allotment date is 18 November, 2024.


Q.What is the Mangal Compusolution IPO Listing Date?

Ans.Mangal Compusolution IPO listing date is 20 November, 2024. The IPO is to list on BSE.